Qomatropin HGH Pharmaqo

£390.00

Qomatropin HGH Pharmaqo is a pharmaceutical-grade somatropin formulation designed for advanced in-vitro research applications investigating growth hormone mechanisms and cellular signaling pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Qomatropin HGH Pharmaqo
Qomatropin HGH Pharmaqo
£390.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Laboratory-Grade Growth Hormone Research Compound

Qomatropin HGH Pharmaqo is a pharmaceutical-grade somatropin formulation specifically manufactured for comprehensive in-vitro laboratory research applications. This recombinant human growth hormone compound enables researchers to investigate the complex mechanisms of growth hormone signaling pathways, cellular proliferation dynamics, and metabolic regulation at the molecular level. Scientists can examine how somatropin interacts with growth hormone receptors and analyse its effects on IGF-1 expression in controlled laboratory environments.

Advanced Research Applications

Research teams utilize this growth hormone compound to study protein synthesis mechanisms, investigate cellular repair processes, and evaluate metabolic pathway modulation in cell culture systems. The compound proves valuable for examining growth hormone’s role in tissue regeneration, bone metabolism research, and age-related cellular changes. Researchers at Stroid UK Shop particularly value its consistent molecular structure for reproducible experimental outcomes across multiple study protocols.

Advanced applications include investigating growth hormone’s interaction with other compounds from our growth hormone collection, comparative studies with selective androgen receptor modulators, and combinatorial research with research peptides to understand synergistic cellular mechanisms.

Specification Overview

Qomatropin HGH Pharmaqo Research Specifications
Parameter Specification
Molecular Formula C₉₉₀H₁₅₂₈N₂₆₂O₃₀₀S₇
Molecular Weight 22,124.12 g/mol
Purity ≥98% (HPLC verified)
Form Lyophilised powder
Storage 2-8°C, protected from light
Solubility Water, buffered saline solutions

Research Compliance Statement

Qomatropin HGH Pharmaqo is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any clinical applications. This compound must be handled by qualified research personnel in appropriate laboratory facilities following established safety protocols. Researchers should maintain proper documentation of all experimental procedures and ensure compliance with relevant institutional guidelines for research chemical handling.

Related